Alliance Pharmaceutical setback for German Oxygent trial
This article was originally published in Clinica
Executive Summary
A German ethics committee has rejected Alliance Pharmaceutical's appeal to start a phase 2 clinical trial of its intravascular oxygen carrier, Oxygent, in the prevention of post-op ileus resulting from hypoxia during major surgery.